Utah People's Post

The Latest News from the Beehive State

Saturday, September 23, 2023
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Archives for Novartis

EU Approved Signifor, Novartis’ New Acromegaly Drug

November 24, 2014 Posted by Contributor

On Monday, Signifor – Novartis’ newest drug aimed at treating a rare hormonal disorder called acromegaly – was approved by the European Union. Signifor is now available in 27 European member states, including Iceland and Norway. An application for Signifor’s approval had been also currently filed in the US. The European Commission’s approval for Novartis’ new acromegaly drug was mainly based on … [Read more...]

Filed Under: Health Tagged With: acromegaly disorder, excess growth of hormones, GH and IGF1, new treatment for acromegaly, Novartis, Sandostatin LAR, Signifor EU release, somatostatin analogues, SSA

Cardio Drug Novel Novartis Faced Rejection By FDA

May 16, 2014 Posted by Staff

A complete response letter has been issued by FDA in context with the biologics license application for RLX030, Novartis reported. The move is the latest blow to a treatment Novartis yearned would be a keystone of a cardiovascular franchise. Also known as serelaxin, the drug is similar to the naturally occurring human hormone relaxin-2, which has been found to help women adjust to the … [Read more...]

Filed Under: Health Tagged With: Cardio, cardio drug, FDA, heart failure drug, Novartis, novel novartis, rejected fda, serelaxin

Novartis’ Signifor LAR therapy highly effective in acromegaly patients

May 5, 2014 Posted by Contributor

Swiss drug maker Novartis on Monday presented the final-stage trial of Signifor long-acting release (LAR) therapy and expressed confidence that it can do wonders in treating patients with the endocrine disorder acromegaly than existing therapies. The clinical trial was presented at the 16th European Congress of Endocrinology3. The study, conducted by Novartis, showed that patients who took … [Read more...]

Filed Under: Health Tagged With: acromegaly, LAR therapy, long-acting release, Novartis, Novartis drug, Signifor

FDA gives green signal to Novartis’s ‘Zykadia’ to treat lung cancer

April 30, 2014 Posted by Contributor

The U.S. Food and Drug Administration has give its green signal to Novartis's new therapy drug 'Zykadia'(ceritinib) to treat a certain type of late stag non-small cell lung cancer (NSCLC). The early approval comes as a surprise as FDA was expected to finish reviewing the drug application by August 24, 2014 and then pronounce its verdict. Zykadia is the fourth drug with breakthrough … [Read more...]

Filed Under: Health Tagged With: FDA, lung cancer, lung cancer therapy, lung cancer treatment, non-small cell lung cancer, Novartis, NSCLC, Zykadia

Novartis To Seek Approval For Heart Failure Drug LCZ696 As Trial Ends Positively

March 31, 2014 Posted by Contributor

Bolstering its prospects of getting cardiovascular franchise, Swiss company Novartis is going to seek approval for an experimental heart failure treatment sooner than it had expected. An independent panel has recommended Novartis to close a late-stage trial for a twice-a-day pill LCZ696 after the clinical trial results showed patients taking the drug lived longer without being … [Read more...]

Filed Under: Health Tagged With: LCZ696, Novartis, Novartis Heart Failure Drug

Novartis plans to approach FDA as its Plaque psoriasis drug clears trial

March 22, 2014 Posted by Contributor

Swiss drugmaker Novartis on Saturday said that its experimental drug secukinumab proved to be more effective than Enbrel at clearing psoriasis in a phase III clinical trial. According to the firm, the drug showed good results in a two late-stage clinical trials when used by patients suffering from moderate-to-severe plaque psoriasis. The study findings were presented at the American Academy … [Read more...]

Filed Under: Health Tagged With: FDA, Novartis, Plaque psoriasis, secukinumab

Novartis in trouble for breaking trial protocol in Japan

January 20, 2014 Posted by Contributor

The employees of Swiss drugmaker Novartis are under fire for violating a trial protocol by inappropriately transferring clinical test results for one of its cancer drugs. According to the drugmaker, the employee at its Japanese unit violated clinical trial rules by wrongfully indulging in the transfer of data on a cancer drug from research centers to University of Tokyo Hospital. Meanwhile, … [Read more...]

Filed Under: Health Tagged With: Novartis, Novartis in Japan, Novartis trial protocol, University of Tokyo Hospital

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

June 29, 2018 By Amelia Donovan

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

June 29, 2018 By Amelia Donovan

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

June 28, 2018 By Amelia Donovan

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

June 27, 2018 By Amelia Donovan

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

June 27, 2018 By Amelia Donovan

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

June 26, 2018 By Amelia Donovan

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

June 25, 2018 By Amelia Donovan

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

June 23, 2018 By Amelia Donovan

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

June 22, 2018 By Amelia Donovan

456 People Dead at U.K. Hospital after Taking too Many Painkillers

June 21, 2018 By Amelia Donovan

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

June 20, 2018 By Amelia Donovan

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2023 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact